Literature DB >> 28410559

The "Iron"-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease.

Suzanne M Cloonan1, Sharon Mumby2, Ian M Adcock2, Augustine M K Choi1,3, Kian Fan Chung2, Gregory J Quinlan4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28410559      PMCID： PMC5694836          DOI： 10.1164/rccm.201702-0311PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  124 in total

1.  Influence of DMT1 and iron status on inflammatory responses in the lung.

Authors:  Jonghan Kim; Ramon M Molina; Thomas C Donaghey; Peter D Buckett; Joseph D Brain; Marianne Wessling-Resnick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-28       Impact factor: 5.464

2.  Persistence of respiratory symptoms in ex-underground iron ore miners.

Authors:  Ulf Hedlund; B Järvholm; B Lundbäck
Journal:  Occup Med (Lond)       Date:  2006-06-09       Impact factor: 1.611

3.  Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major.

Authors:  Aldo Filosa; Angela Vitrano; Paolo Rigano; Giuseppina Calvaruso; Rita Barone; Marcello Capra; Liana Cuccia; Francesco Gagliardotto; Lorella Pitrolo; Luciano Prossomariti; Maddalena Casale; Vincenzo Caruso; Calogera Gerardi; Saveria Campisi; Paolo Cianciulli; Michele Rizzo; Giuseppe D'Ascola; Angela Ciancio; Aurelio Maggio
Journal:  Blood Cells Mol Dis       Date:  2013-04-28       Impact factor: 3.039

4.  Neutrophil elastase increases airway epithelial nonheme iron levels.

Authors:  Bernard M Fischer; Denise A Lopez Domowicz; Shuo Zheng; Jamie L Carter; N Gerry McElvaney; Clifford Taggart; James R Lehmann; Judith A Voynow; Andrew J Ghio
Journal:  Clin Transl Sci       Date:  2009-10       Impact factor: 4.689

5.  Low erythropoietin plasma levels during exacerbations of COPD.

Authors:  Ernest Sala; Catalina Balaguer; Cristina Villena; Angel Ríos; Aina Noguera; Belén Núñez; Alvar Agustí
Journal:  Respiration       Date:  2009-12-02       Impact factor: 3.580

Review 6.  Inflammatory response of lung macrophages and epithelial cells to tobacco smoke: a literature review of ex vivo investigations.

Authors:  Lauren A Smith; Geraldine M Paszkiewicz; Alan D Hutson; John L Pauly
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

7.  Alveolar macrophage content of isoferritins and transferrin. Comparison of nonsmokers and smokers with and without chronic airflow obstruction.

Authors:  L J Wesselius; C H Flowers; B S Skikne
Journal:  Am Rev Respir Dis       Date:  1992-02

8.  Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases.

Authors:  Iwona Ziółkowska-Suchanek; Maria Mosor; Piotr Gabryel; Marcin Grabicki; Magdalena Żurawek; Marta Fichna; Ewa Strauss; Halina Batura-Gabryel; Wojciech Dyszkiewicz; Jerzy Nowak
Journal:  Sci Rep       Date:  2015-08-27       Impact factor: 4.379

9.  Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron.

Authors:  Donald S Silverberg; Ram Mor; Melanie Tia Weu; Doron Schwartz; Idit F Schwartz; Gil Chernin
Journal:  BMC Pulm Med       Date:  2014-02-24       Impact factor: 3.317

Review 10.  Metabolic reprograming in macrophage polarization.

Authors:  Silvia Galván-Peña; Luke A J O'Neill
Journal:  Front Immunol       Date:  2014-09-02       Impact factor: 7.561
View more
  27 in total

1.  The immune system as a victim and aggressor in chronic obstructive pulmonary disease.

Authors:  Joshua J C McGrath; Martin R Stampfli
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 2.  Mitochondria: at the crossroads of regulating lung epithelial cell function in chronic obstructive pulmonary disease.

Authors:  Mahyar Aghapour; Alexander H V Remels; Simon D Pouwels; Dunja Bruder; Pieter S Hiemstra; Suzanne M Cloonan; Irene H Heijink
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-06       Impact factor: 5.464

3.  Lung proteomic biomarkers associated with chronic obstructive pulmonary disease.

Authors:  Yu-Hang Zhang; Michael R Hoopmann; Peter J Castaldi; Kirsten A Simonsen; Mukul K Midha; Michael H Cho; Gerard J Criner; Raphael Bueno; Jiangyuan Liu; Robert L Moritz; Edwin K Silverman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-20       Impact factor: 5.464

Review 4.  Recent evidence from omic analysis for redox signalling and mitochondrial oxidative stress in COPD.

Authors:  Sharon Mumby; Ian M Adcock
Journal:  J Inflamm (Lond)       Date:  2022-07-11       Impact factor: 6.283

Review 5.  Iron-Deficiency in Atopic Diseases: Innate Immune Priming by Allergens and Siderophores.

Authors:  Franziska Roth-Walter
Journal:  Front Allergy       Date:  2022-05-10

6.  Hepcidin Is Essential for Alveolar Macrophage Function and Is Disrupted by Smoke in a Murine Chronic Obstructive Pulmonary Disease Model.

Authors:  Elizabeth Perez; Jonathan R Baker; Silvana Di Giandomenico; Pouneh Kermani; Jacqueline Parker; Kihwan Kim; Jianjun Yang; Peter J Barnes; Sophie Vaulont; Joseph M Scandura; Louise E Donnelly; Heather Stout-Delgado; Suzanne M Cloonan
Journal:  J Immunol       Date:  2020-09-21       Impact factor: 5.422

Review 7.  Modern iron replacement therapy: clinical and pathophysiological insights.

Authors:  Domenico Girelli; Sara Ugolini; Fabiana Busti; Giacomo Marchi; Annalisa Castagna
Journal:  Int J Hematol       Date:  2017-12-01       Impact factor: 2.490

8.  Update in Chronic Obstructive Pulmonary Disease 2020.

Authors:  Andy I Ritchie; Jonathon R Baker; Trisha M Parekh; James P Allinson; Surya P Bhatt; Louise E Donnelly; Gavin C Donaldson
Journal:  Am J Respir Crit Care Med       Date:  2021-07-01       Impact factor: 21.405

9.  Factors associated with serum ferritin levels and iron excess: results from the EPIC-EurGast study.

Authors:  Lucía Iglesias-Vázquez; Victoria Arija; Núria Aranda; Elom K Aglago; Amanda J Cross; Matthias B Schulze; Daniel Quintana Pacheco; Tilman Kühn; Elisabete Weiderpass; Rosario Tumino; Daniel Redondo-Sánchez; Maria Santucci de Magistris; Domenico Palli; Eva Ardanaz; Nasser Laouali; Emily Sonestedt; Isabel Drake; Lucía Rizzolo; Carmen Santiuste; Carlotta Sacerdote; Ramón Quirós; Pilar Amiano; Antonio Agudo; Paula Jakszyn
Journal:  Eur J Nutr       Date:  2021-07-02       Impact factor: 5.614

10.  The Ferroxidase Hephaestin in Lung Cancer: Pathological Significance and Prognostic Value.

Authors:  Paola Zacchi; Beatrice Belmonte; Alessandro Mangogna; Gaia Morello; Letizia Scola; Anna Martorana; Violetta Borelli
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.